The impact of TRA on global CVD risk as well as individual risk factors is ambiguous , but a tendency towards slight reduction of blood pressure , total cholesterol and smoking levels , especially in high risk patient groups was observed .
TRA had no influence on lifestyle behaviour .
Conclusions There is limited evidence , of low overall quality , suggesting a possible lack of effectiveness of TRA in reducing CVD events and mortality , as well as a clinical ly insignificant influence on individual risk factor levels .
Background Our objectives were to critically appraise and summarise the current evidence for the effectiveness of using cardiovascular disease ( CVD ) risk scoring ( total risk assessment - TRA ) in routine risk assessment in primary prevention of CVD compared with st and ard care with regards to patients outcomes , clinical risk factor levels , medication prescribing , and adverse effects .
The origins, evolution, and future of The Cochrane Database of Systematic Reviews.
The Cochrane Data base of Systematic Review s ( CDSR ) evolved in response to Archie Cochrane 's challenge to the medical profession to assemble " a critical summary , adapted periodically , of all ... relevant r and omized controlled trials " . CDSR has been an electronic publication from its inception and this has meant that Cochrane review s ( i ) need not be constrained by lack of space ; ( ii ) can be up date d as new information becomes available and when mistakes or other ways of improving them are identified ; and ( iii ) can be cross-linked to other , related sources of relevant information . Although CDSR has become widely cited , it must continue to evolve in the light of technological and method ological developments , and in response to the needs of people making decisions about health care
The impact of TRA on global CVD risk as well as individual risk factors is ambiguous , but a tendency towards slight reduction of blood pressure , total cholesterol and smoking levels , especially in high risk patient groups was observed .
TRA had no influence on lifestyle behaviour .
Conclusions There is limited evidence , of low overall quality , suggesting a possible lack of effectiveness of TRA in reducing CVD events and mortality , as well as a clinical ly insignificant influence on individual risk factor levels .
Background Our objectives were to critically appraise and summarise the current evidence for the effectiveness of using cardiovascular disease ( CVD ) risk scoring ( total risk assessment - TRA ) in routine risk assessment in primary prevention of CVD compared with st and ard care with regards to patients outcomes , clinical risk factor levels , medication prescribing , and adverse effects .